Literature DB >> 15773824

FRAMIG 2000: medical and therapeutic management of migraine in France.

C Lucas1, C Chaffaut, M-A Artaz, M Lantéri-Minet.   

Abstract

FRAMIG 2000 is a population-based survey of medical and therapeutic management of migraine in France. A total of 312 migraine sufferers were first identified from a representative sample of 4689 adult subjects using a validated questionnaire based on the IHS migraine diagnostic criteria and administered by telephone. Subjects were then interviewed using a branching questionnaire and a computer-assisted interview technique. Although 80% were self-aware of their migrainous state, 82% of migraine sufferers had no medical follow-up for migraine. The proportion of migraine sufferers who did not consult decreased slightly with increasing migraine-related disability (from 87% for subjects in MIDAS grade I to 68% for those in MIDAS grade IV). Migraine sufferers declared to effectively control only four attacks out of 10 after the first intake of the usual treatment. Only 6% of subjects in the survey received a prophylactic treatment for migraine whereas 22% were in MIDAS grade III or IV. These data show that the burden of migraine does not result from a deficit in diagnosis but instead from a deficit in patient information on the proper use of current effective treatments of migraine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773824     DOI: 10.1111/j.1468-2982.2004.00851.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  14 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Treatment of migraine and tension-type headache in Croatia.

Authors:  Vlasta Vuković; Davor Plavec; Arijana Lovrencić Huzjan; Mislav Budisić; Vida Demarin
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

3.  Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study.

Authors:  A C Lyngberg; B K Rasmussen; T Jørgensen; R Jensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  [Clinical use of triptans in the management of migraine].

Authors:  Michel Lantéri-Minet
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Impact of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andrée
Journal:  J Headache Pain       Date:  2008-04-17       Impact factor: 7.277

6.  Impact of a public sensitization campaign on migraine management in France.

Authors:  Anne Donnet; Michel Lantéri-Minet; Gilles Géraud; Evelyne Guegan-Massardier; Geneviève Demarquay; Pierric Giraud; Christian Lucas; Dominique Valade
Journal:  J Headache Pain       Date:  2009-05-30       Impact factor: 7.277

7.  Triptans in the Italian population: a drug utilization study and a literature review.

Authors:  Alessandro Panconesi; Eleonora Pavone; Franca Vacca; Monica Vaiani; Roberto Banfi
Journal:  J Headache Pain       Date:  2008-03-04       Impact factor: 7.277

8.  Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.

Authors:  Steffen Naegel; Mark Obermann
Journal:  Neuropsychiatr Dis Treat       Date:  2010-02-03       Impact factor: 2.570

9.  Anthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings.

Authors:  Harald J Hamre; Claudia M Witt; Gunver S Kienle; Anja Glockmann; Renatus Ziegler; Andreas Rivoir; Stefan N Willich; Helmut Kiene
Journal:  Open Neurol J       Date:  2010-09-08

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.